Axq Capital, LP Exelixis, Inc. Transaction History
Axq Capital, LP
- $417 Billion
- Q1 2024
A detailed history of Axq Capital, LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 13,000 shares of EXEL stock, worth $293,800. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,000Holding current value
$293,800% of portfolio
0.07%Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
463Shares Held
247MCall Options Held
1.7MPut Options Held
1.02M-
Black Rock Inc. New York, NY34.9MShares$788 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$697 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA26.7MShares$603 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.1MShares$341 Million0.56% of portfolio
-
State Street Corp Boston, MA13.1MShares$296 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $7.27B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...